ENDRA Life Sciences expands into China with Shanghai General Hospital partnership
Therapeutics | News | 0 Comment | 25 Jan, 2022
US-based ENDRA Life Sciences Inc. has received Institutional Review Board approval from China’s Shanghai...Read more
Singapore develops new therapeutic approach to treat metabolic disorders
Therapeutics | News | 0 Comment | 25 Jan, 2022
Scientists at Nanyang Technological University, Singapore (NTU Singapore) have developed a new therapeutic approach to o...Read more
Australia discovers new antimicrobial therapeutics to fight superbugs
Therapeutics | News | 0 Comment | 24 Jan, 2022
Researchers from Monash University in Australia have discovered a potential new way to prevent antibiotic resistance and...Read more
Industrial chemical Bisphenol S increases cancer risk: China study
Therapeutics | News | 0 Comment | 20 Jan, 2022
A study led by Hong Kong Baptist University (HKBU) has revealed that different degrees of exposure to bisphenol S (BPS),...Read more
Australia to launch first collaborative cardiovascular research accelerator
Therapeutics | News | 0 Comment | 19 Jan, 2022
Federal Minister for Health, Greg Hunt has announced funding for two new Research Centres through the MTPConnect Targete...Read more
Singapore finds antibody capable of neutralising major SARS-CoV2 variants of concern
Therapeutics | News | 0 Comment | 18 Jan, 2022
In a study jointly conducted by the Bio-Safety Level 3 (BSL3) Core Facility at the NUS Yong Loo Lin School of Medicine (...Read more
Hong Kong develops anti-virus 3D printing material to rapidly terminate COVID-19
Therapeutics | News | 0 Comment | 17 Jan, 2022
An interdisciplinary research team from The Hong Kong Polytechnic University (PolyU) has successfully developed the worl...Read more
Singapore deepens interest in dengue virus transmission
Therapeutics | News | 0 Comment | 17 Jan, 2022
Software-analysed high-resolution videos have revealed that dengue-infected mosquitos are more attracted to mammals and ...Read more
Australia uncovers resistance gene in deadly E. coli
Therapeutics | News | 0 Comment | 14 Jan, 2022
Scientists have pinpointed a gene that helps deadly E. coli bacteria evade antibiotics, potentially leading to better tr...Read more
Singapore's SCG Cell Therapy acquires technology from A*STAR for novel cancer treatment
Therapeutics | News | 0 Comment | 13 Jan, 2022
Singapore-based SCG Cell Therapy has acquired the rights to human “induced pluripotent stem cell” ...Read more
Australia leads world-first clinical trial on benefits of losing weight prior to pregnancy
Therapeutics | News | 0 Comment | 13 Jan, 2022
The University of Sydney, Australia is leading the world's largest clinical trial exploring how losing weight prior to p...Read more
Hong Kong dissects lung carcinoma at single-cell resolution uncovering new mechanism
Therapeutics | News | 0 Comment | 13 Jan, 2022
Tumour formation is a multistep and complex process and the underlying mechanism behind it is still largely unclear. A n...Read more
Korean firm partners with Sanofi for Parkinson's Disease treatment
Therapeutics | News | 0 Comment | 12 Jan, 2022
ABL Bio, Inc., a South Korea-based clinical-stage biotech developing bispecific antibody technology for immuno-oncology ...Read more
Australia discovers new treatments for infectious diseases
Therapeutics | News | 0 Comment | 11 Jan, 2022
Researchers at the Peter Doherty Institute for Infection and Immunity (Doherty Institute) in Australia have disc...Read more
Japan develops cancer therapy using on-site synthesis of anti-cancer drugs
Therapeutics | News | 0 Comment | 10 Jan, 2022
An international research group at the RIKEN Cluster for Pioneering Research (CPR) in Japan has successfully treated can...Read more
Rare cancers & rare diseases research receives $63.4M boost in Australia
Therapeutics | News | 0 Comment | 10 Jan, 2022
Research into some of the world’s rarest forms of cancer and disease have received a boost, with the Australian go...Read more
Korea-based LISCure Biosciences explores treatment for rare liver diseases
Therapeutics | News | 0 Comment | 07 Jan, 2022
LISCure Biosciences Inc., a South Korea-based biotech startup, has executed a research collaboration agreement with US b...Read more
Mental health clinical trials receive funding worth $14.8 M in Australia
Therapeutics | News | 0 Comment | 07 Jan, 2022
Seven clinical trials testing the use of potential breakthrough combination therapies to treat debilitating mental illne...Read more